Literature DB >> 21091605

Altered mitochondrial regulation in quadriceps muscles of patients with COPD.

Ashley I Naimi1, Jean Bourbeau, Helene Perrault, Jacinthe Baril, Cynthia Wright-Paradis, Amanda Rossi, Tanja Taivassalo, A William Sheel, Rasmus Rabøl, Flemming Dela, Robert Boushel.   

Abstract

Evidence exists for locomotor muscle impairment in patients with chronic obstructive pulmonary disease (COPD), including fiber type alterations and reduced mitochondrial oxidative capacity. In this study high-resolution respirometry was used to quantify oxygen flux in permeabilized fibres from biopsies of the vastus lateralis muscle in patients with COPD and compared to healthy control subjects. The main findings of this study were that (i) routine state 2 respiration was higher in COPD; (ii) state 3 respiration in the presence of ADP was similar in both groups with substrate supply of electrons to complex I (COPD 38·28 ± 3·58 versus control 42·85 ± 3·10 pmol s(-1) mg tissue(-1) ), but O(2) flux with addition of succinate was lower in COPD patients (COPD 63·72 ± 6·33 versus control 95·73 ± 6·53 pmol s(-1) mg tissue(-1) ); (iii) excess capacity of cytochrome c oxidase in COPD patients was only ~50% that of control subjects. These results indicate that quadriceps muscle mitochondrial function is altered in patients with COPD. The regulatory mechanisms underlying these functional abnormalities remain to be uncovered.
© 2010 The Authors. Clinical Physiology and Functional Imaging © 2010 Scandinavian Society of Clinical Physiology and Nuclear Medicine.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21091605     DOI: 10.1111/j.1475-097X.2010.00988.x

Source DB:  PubMed          Journal:  Clin Physiol Funct Imaging        ISSN: 1475-0961            Impact factor:   2.273


  16 in total

1.  Quadriceps exercise intolerance in patients with chronic obstructive pulmonary disease: the potential role of altered skeletal muscle mitochondrial respiration.

Authors:  Jayson R Gifford; Joel D Trinity; Gwenael Layec; Ryan S Garten; Song-Young Park; Matthew J Rossman; Steen Larsen; Flemming Dela; Russell S Richardson
Journal:  J Appl Physiol (1985)       Date:  2015-08-13

2.  Cigarette smoke directly impairs skeletal muscle function through capillary regression and altered myofibre calcium kinetics in mice.

Authors:  Leonardo Nogueira; Breanna M Trisko; Frederico L Lima-Rosa; Jason Jackson; Helena Lund-Palau; Masahiro Yamaguchi; Ellen C Breen
Journal:  J Physiol       Date:  2018-06-19       Impact factor: 5.182

Review 3.  Molecular and biological pathways of skeletal muscle dysfunction in chronic obstructive pulmonary disease.

Authors:  Esther Barreiro; Joaquim Gea
Journal:  Chron Respir Dis       Date:  2016-04-06       Impact factor: 2.444

4.  Beclin-1 regulates cigarette smoke-induced kidney injury in a murine model of chronic obstructive pulmonary disease.

Authors:  Maria A Pabón; Edwin Patino; Divya Bhatia; Joselyn Rojas-Quintero; Kevin C Ma; Eli J Finkelsztein; Juan C Osorio; Faryal Malick; Francesca Polverino; Caroline A Owen; Stefan W Ryter; Augustine Mk Choi; Suzanne M Cloonan; Mary E Choi
Journal:  JCI Insight       Date:  2018-09-20

Review 5.  Muscle atrophy in chronic obstructive pulmonary disease: molecular basis and potential therapeutic targets.

Authors:  Esther Barreiro; Ariel Jaitovich
Journal:  J Thorac Dis       Date:  2018-05       Impact factor: 2.895

Review 6.  An official American Thoracic Society/European Respiratory Society statement: update on limb muscle dysfunction in chronic obstructive pulmonary disease.

Authors:  François Maltais; Marc Decramer; Richard Casaburi; Esther Barreiro; Yan Burelle; Richard Debigaré; P N Richard Dekhuijzen; Frits Franssen; Ghislaine Gayan-Ramirez; Joaquim Gea; Harry R Gosker; Rik Gosselink; Maurice Hayot; Sabah N A Hussain; Wim Janssens; Micheal I Polkey; Josep Roca; Didier Saey; Annemie M W J Schols; Martijn A Spruit; Michael Steiner; Tanja Taivassalo; Thierry Troosters; Ioannis Vogiatzis; Peter D Wagner
Journal:  Am J Respir Crit Care Med       Date:  2014-05-01       Impact factor: 21.405

7.  Altered skeletal muscle mitochondrial phenotype in COPD: disease vs. disuse.

Authors:  Jayson R Gifford; Joel D Trinity; Oh-Sung Kwon; Gwenael Layec; Ryan S Garten; Song-Young Park; Ashley D Nelson; Russell S Richardson
Journal:  J Appl Physiol (1985)       Date:  2017-12-28

Review 8.  Autophagy: a crucial moderator of redox balance, inflammation, and apoptosis in lung disease.

Authors:  Kiichi Nakahira; Suzanne M Cloonan; Kenji Mizumura; Augustine M K Choi; Stefan W Ryter
Journal:  Antioxid Redox Signal       Date:  2013-09-26       Impact factor: 8.401

9.  Biomarkers of mitochondrial content in skeletal muscle of healthy young human subjects.

Authors:  Steen Larsen; Joachim Nielsen; Christina Neigaard Hansen; Lars Bo Nielsen; Flemming Wibrand; Nis Stride; Henrik Daa Schroder; Robert Boushel; Jørn Wulff Helge; Flemming Dela; Martin Hey-Mogensen
Journal:  J Physiol       Date:  2012-05-14       Impact factor: 5.182

10.  Erythropoietin treatment enhances muscle mitochondrial capacity in humans.

Authors:  Ulla Plenge; Bo Belhage; Amelia Guadalupe-Grau; Peter Riis Andersen; Carsten Lundby; Flemming Dela; Nis Stride; Frank Christian Pott; Jørn W Helge; Robert Boushel
Journal:  Front Physiol       Date:  2012-03-13       Impact factor: 4.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.